Advisory Services Network’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Other funds holding ATNM
CFM
GS
Advisory Services Network's ATNM Position: Q2 2026 in Review
Advisory Services Network sold out of Actinium Pharmaceuticals (ATNM) in Q2 2026, closing a stake of 1,460 shares — an estimated $1.45K sold.
Advisory Services Network first reported a position in ATNM in Q4 2022 and held it in 5 quarters. The position peaked at $14.2K in Q1 2023. 47 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.
- Advisory Services Network reported no remaining Actinium Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 1,460 Actinium Pharmaceuticals shares in Q2 2026, an estimated $1.45K.
- Advisory Services Network first reported a position in Actinium Pharmaceuticals in Q4 2022 and held it in 5 quarters.
- Advisory Services Network's Actinium Pharmaceuticals position peaked at $14.2K in Q1 2023.
- 47 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.